FDA-Drug2024-07-17Class II
Lidocaine HCL Injection, USP 2% 200mg/10mL (20mg/mL) and EPINEPHRINE HCl 1:200,000, 10 ml Single Dose Vial, Rx only, Compounded drug by Medivant Healthcare, 158 S Kyrene Rd, Chandler, AZ 85226, NDC 81483-0038-0, UPC 3 81483 00380 2
TAILSTORM HEALTH INC
Hazard
Subpotent Drug: reduced efficacy for epinephrine
Sold states
Nationwide in the USA
Affected count
12,525 10 mL vials
Manufactured in
158 S Kyrene Rd, N/A, Chandler, AZ, United States
Products
Lidocaine HCL Injection, USP 2% 200mg/10mL (20mg/mL) and EPINEPHRINE HCl 1:200,000, 10 ml Single Dose Vial, Rx only, Compounded drug by Medivant Healthcare, 158 S Kyrene Rd, Chandler, AZ 85226, NDC 81483-0038-0, UPC 3 81483 00380 2
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0594-2024Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief